Skip to main navigation Skip to search Skip to main content

Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites

    Research output: Contribution to journal › Article › peer-review

    103   Link opens in a new tab Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites'. Together they form a unique fingerprint.
    Sort by

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science